SFA Therapeutics, Inc., a clinical-stage biopharmaceutical company developing oral small-molecule biosynthetic compounds for ...

"Ashley did a lot of self-blaming," mom Bailey Velikaneye, 29, told Newsweek: "To this day, it haunts me to hear her say those words." ...

In this medical fiction tale, a journalist's attempt to expose what he believes to be a secret gender-affirming care clinic in a hospital basement turns deadly.

KOCHI: George (name changed), was 55-years-old when he was diagnosed with fatty liver. Since he was a teetotaller, he did not ...

Phase 2 filing on track for Q1 2025 "The acceptance of our third U.S. IND is an important milestone for Aligos,” said ...

Planned industry first clinical trial combining BeiGene's checkpoint inhibitor tislelizumab with Indaptus’ broadly targeted, short duration ...

Tremelimumab has been approved by the FDA in the US for use in tandem with AZ's PD-L1 inhibitor Imfinzi (durvalumab) to treat adults with unresectable hepatocellular carcinoma (HCC), the most ...

Early study data from Wave Life Sciences suggests how editing RNA may yield viable medicines. Large and small drugmakers say ...

Delhi HC closed contempt proceedings against Wikipedia after the platform globally removed a defamatory page. The court criticized Wikipedia for refusing to disclose user identities responsible ...

Phuket Smart Bus (PKSB) yesterday launched a new electric bus service connecting Phuket Town and Patong. The service is priced at just 50 baht per passenger. The launch yesterday, October 9, saw ...